NCT06629402View on ClinicalTrials.gov

Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 5, 2023

Primary Completion Date

November 14, 2023

Study Completion Date

November 15, 2023

Conditions
Acute Pain
Interventions
DRUG

PF614

Experimental oxycodone prodrug

DRUG

Placebo

Inactive medication

Trial Locations (1)

66212

Dr. Vince Clinical Research, Overland Park

Sponsors
All Listed Sponsors
collaborator

Dr. Vince Clinical Research

OTHER

lead

Ensysce Biosciences

INDUSTRY